U.S. flag

An official website of the United States government

NM_000443.4(ABCB4):c.3370dup (p.Cys1124fs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 13, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003083388.2

Allele description [Variation Report for NM_000443.4(ABCB4):c.3370dup (p.Cys1124fs)]

NM_000443.4(ABCB4):c.3370dup (p.Cys1124fs)

Gene:
ABCB4:ATP binding cassette subfamily B member 4 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
7q21.12
Genomic location:
Preferred name:
NM_000443.4(ABCB4):c.3370dup (p.Cys1124fs)
HGVS:
  • NC_000007.14:g.87406404dup
  • NG_007118.3:g.74623dup
  • NM_000443.3:c.3370dupT
  • NM_000443.4:c.3370dupMANE SELECT
  • NM_018849.3:c.3391dup
  • NM_018850.3:c.3229dup
  • NP_000434.1:p.Cys1124fs
  • NP_061337.1:p.Cys1131fs
  • NP_061338.1:p.Cys1077fs
  • NC_000007.13:g.87035719_87035720insA
  • NC_000007.13:g.87035720dup
  • NG_007118.2:g.79029dup
Protein change:
C1077fs
Molecular consequence:
  • NM_000443.4:c.3370dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_018849.3:c.3391dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_018850.3:c.3229dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003457415Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jun 13, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).

Degiorgio D, Colombo C, Seia M, Porcaro L, Costantino L, Zazzeron L, Bordo D, Coviello DA.

Eur J Hum Genet. 2007 Dec;15(12):1230-8. Epub 2007 Aug 29.

PubMed [citation]
PMID:
17726488

Progressive familial intrahepatic cholestasis.

Srivastava A.

J Clin Exp Hepatol. 2014 Mar;4(1):25-36. doi: 10.1016/j.jceh.2013.10.005. Epub 2013 Nov 23. Review.

PubMed [citation]
PMID:
25755532
PMCID:
PMC4017198
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV003457415.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with ABCB4-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.03%). This sequence change creates a premature translational stop signal (p.Cys1124Leufs*20) in the ABCB4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCB4 are known to be pathogenic (PMID: 17726488, 25755532).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024